A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.

Clinical trial NCT00502671 · COMPLETED

Trial details

NCT number: NCT00502671
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2007-07-01
Primary completion: 2012-03-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.